american diabetes association pancreatitis glp-1 receptor agonist history Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Frontiers | GLP-1 Receptor Agonists:

[DOI] [PMC free article] [PubMed] [Google Scholar] 230.Aviles-Olmos I., Dickson J., Kefalopoulou Z., Djamshidian A., Ell P., Soderlund T

For many people with obesity or type 2 diabetes, those signals are weak or disrupted

In this study, participants taking orforglipron experienced an average A1C reduction of 2.1% and an average weight loss of 10.1 kilograms at 26 weeks, which was significantly greater than those in the placebo and dulaglutide groups

This is my personal experience

Hamel, KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs

Since semaglutides patent expired in India in March 2026, generic prices have fallen by roughly 80%, with monthly costs now starting around 1,290 to 5,000 compared with 8,800 to 16,400 for older branded options